Position in LENZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,622,117
-$2,962,005 QoQ
Shares Held
285,584
-43.0% QoQ
Ownership
0.909%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LENZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,283,358,070 across 343 Biotechnology names. LENZ ranks #177 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in LENZ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,622,117 | 285,584 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,584,122 | 500,997 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,695,136 | 293,446 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,803,277 | 60,182 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $213,958 | 8,322 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $493,070 | 17,079 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $605,536 | 25,507 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $592,632 | 34,276 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||